Literature DB >> 11098900

Additional factors for the estimation of mean glandular breast dose using the UK mammography dosimetry protocol.

D R Dance1, C L Skinner, K C Young, J R Beckett, C J Kotre.   

Abstract

The UK and European protocols for mammographic dosimetry use conversion factors that relate incident air kerma to the mean glandular dose (MGD) within the breast. The conversion factors currently used were obtained by computer simulation of a model breast with a composition of 50% adipose and 50% glandular tissues by weight (50% glandularity). Relative conversion factors have been calculated which allow the extension of the protocols to breasts of varying glandularity and for a wider range of mammographic x-ray spectra. The data have also been extended to breasts of a compressed thickness of 11 cm. To facilitate the calculation of MGD in patient surveys, typical breast glandularities are tabulated for women in the age ranges 40-49 and 50-64 years, and for breasts in the thickness range 2-11 cm. In addition, tables of equivalent thickness of polymethyl methacrylate have been provided to allow the simulation for dosimetric purposes of typical breasts of various thicknesses.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 11098900     DOI: 10.1088/0031-9155/45/11/308

Source DB:  PubMed          Journal:  Phys Med Biol        ISSN: 0031-9155            Impact factor:   3.609


  79 in total

1.  First application of computed radiology to mammography with synchrotron radiation.

Authors:  E Quai; R Longo; F Zanconati; G Jaconelli; M Tonutti; A Abrami; F Arfelli; D Dreossi; G Tromba; M A Cova
Journal:  Radiol Med       Date:  2012-06-28       Impact factor: 3.469

2.  X-ray absorptiometry of the breast using mammographic exposure factors: application to units featuring automatic beam quality selection.

Authors:  C J Kotre
Journal:  Br J Radiol       Date:  2010-06       Impact factor: 3.039

3.  Development of an imaging-planning program for screen/film and computed radiography mammography for breasts with short chest wall to nipple distance.

Authors:  S L Dong; J L Su; Y H Yeh; T C Chu; Y C Lin; K S Chuang
Journal:  Br J Radiol       Date:  2010-12-01       Impact factor: 3.039

4.  Statistical analysis of mammographic breast composition measurements: towards a quantitative measure of relative breast cancer risk.

Authors:  C J Kotre
Journal:  Br J Radiol       Date:  2010-11-16       Impact factor: 3.039

5.  Radiation doses received in the United Kingdom breast screening programme in 2010 to 2012.

Authors:  Kenneth C Young; Jennifer M Oduko
Journal:  Br J Radiol       Date:  2015-12-14       Impact factor: 3.039

6.  Experimental investigation on the choice of the tungsten/rhodium anode/filter combination for an amorphous selenium-based digital mammography system.

Authors:  Paula Toroi; Federica Zanca; Kenneth C Young; Chantal van Ongeval; Guy Marchal; Hilde Bosmans
Journal:  Eur Radiol       Date:  2007-02-01       Impact factor: 5.315

7.  Dose dependence of mass and microcalcification detection in digital mammography: free response human observer studies.

Authors:  Mark Ruschin; Pontus Timberg; Magnus Båth; Bengt Hemdal; Tony Svahn; Rob S Saunders; Ehsan Samei; Ingvar Andersson; Soren Mattsson; Dev P Chakrabort; Anders Tingber
Journal:  Med Phys       Date:  2007-02       Impact factor: 4.071

8.  Evaluation of mean glandular dose and modulation transfer function for different tube potentials and target-filter combinations in computed radiography mammography.

Authors:  Siti Aishah Abdul Aziz; Abdul Khaliq Mohd Saparudin; Ahmad Zaky Harun
Journal:  Malays J Med Sci       Date:  2013-05

9.  Human-Compatible Multi-Contrast Mammographic Prototype System.

Authors:  Ran Zhang; Ke Li; John W Garrett; Guang-Hong Chen
Journal:  Proc SPIE Int Soc Opt Eng       Date:  2019-03-07

10.  Synthetic breast phantoms from patient based eigenbreasts.

Authors:  Gregory M Sturgeon; Subok Park; William Paul Segars; Joseph Y Lo
Journal:  Med Phys       Date:  2017-10-19       Impact factor: 4.071

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.